SMA Solar (S92) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
14 Jan, 2026Executive summary
Group sales for the first nine months of 2024 declined to €1,059.7 million from €1,337 million year-over-year, mainly due to weakness in Home and C&I segments, while Large Scale & Project Solutions showed strong growth.
EBITDA dropped to €83.5 million from €231 million, impacted by product mix, lower production utilization, and inflationary pressures.
Free cash flow was negative at €220 million, primarily due to increased net working capital.
Net income fell sharply to €34.7 million from €180.4 million year-over-year, with EPS at €1.00 versus €5.20.
A restructuring and transformation program was launched, targeting €150–200 million in cost savings and up to 1,100 FTE reductions globally.
Financial highlights
EBITDA margin fell to 7.9% from 17% year-over-year, with last year benefiting from a favorable product mix and lower costs.
EBIT for Home and C&I segments was significantly negative, while Large Scale EBIT rose to €154.4 million from €47 million, with a margin increase to 20.2%.
Net cash declined from €283 million at 2023 year-end to €45 million, mainly due to net working capital buildup.
Gross cash flow was €53 million, down from €253 million year-over-year.
Capital expenditure rose to €81.5 million (7.7% of sales), up from €58 million (4.3%).
Outlook and guidance
Full-year 2024 sales guidance revised down to €1,450–1,500 million.
Adjusted 2024 EBITDA after restructuring is expected between -€20 million and €20 million.
No significant order intake recovery in Home and C&I expected before H2 2025.
Management anticipates positive cash flow in H2 2025, with restructuring cash outflows mainly in H1.
Significant job cuts of up to 1,100 positions worldwide by end of 2025.
Latest events from SMA Solar
- 2025 revenue flat, losses from one-offs, cash flow up, 2026 outlook cautious on tariffs.S92
Q4 202526 Mar 2026 - Large Scale growth offsets Home and C&I declines; cash flow and outlook remain pressured.S92
Q2 20242 Feb 2026 - 2024 sales and EBITDA declined, but restructuring aims for recovery and EBIT improvement in 2025.S92
Q4 202424 Dec 2025 - Large Scale growth offset weak Home and C&I, with cautious outlook amid tariff and market risks.S92
Q1 202525 Nov 2025 - Sales and margins fell in H1 2025, but cash flow and restructuring efforts improved outlook.S92
Q2 202523 Nov 2025 - Large Scale growth offset by HBS losses and major restructuring; outlook remains challenging.S92
Q3 202517 Nov 2025 - Revenue and earnings fell sharply in 2024, driving a renewed focus on efficiency and innovation.S92
AGM 2025 Presentation1 Jul 2025